Workup for Giant Cell Arteritis
For suspected GCA, obtain temporal artery ultrasound as the first-line diagnostic test, followed by temporal artery biopsy (>1 cm segment, unilateral initially) if ultrasound is unavailable or inconclusive, and obtain baseline inflammatory markers (ESR/CRP) plus noninvasive large vessel imaging to assess extracranial involvement.
Diagnostic Algorithm
Initial Clinical Assessment
Look specifically for:
- Jaw claudication (strongest predictor, 9.0x odds of positive diagnosis) 1
- Neck pain (3.4x odds) 1
- Visual symptoms (amaurosis fugax, vision loss requiring emergency ophthalmologic evaluation with fundoscopy, OCT, and retinal angiography) 2
- Age ≥75 years (2.0x odds) 1
Laboratory Testing
- ESR and CRP together provide optimal sensitivity/specificity 1
First-Line Imaging
Temporal artery ultrasound is now the preferred initial test 3, 4, 2. This represents a significant shift from the 2021 ACR guidelines, which favored biopsy. The 2024 EULAR recommendations and emerging evidence strongly support ultrasound first:
- Include temporal AND axillary arteries in standard examination 3
- Non-invasive, widely available, cost-effective, and can be performed during clinical evaluation 4
- Allows immediate diagnosis in Fast-Track Clinic settings (ideally within 24 hours of presentation) 5
- Requires experienced sonologist (≥300 temporal/axillary examinations for primary operator, ≥50 for secondary) 5
- Use ≥18 MHz probe for temporal arteries, lower frequency for axillary vessels 5
Alternative/Complementary Imaging
If ultrasound is unavailable, inconclusive, or expertise lacking:
Temporal Artery Biopsy 6:
- >1 cm segment (longer preferred due to focal/segmental disease pattern) 6
- Unilateral initially; proceed to contralateral only if first is negative and additional evidence needed 6
- Obtain within 2 weeks of starting glucocorticoids (histopathologic changes more likely detected, though can be positive even after 2 weeks) 6
- The 2021 ACR guidelines conditionally recommend biopsy over ultrasound/MRI for US practitioners due to limited ultrasound expertise 6
Other Imaging Modalities 3, 2:
- FDG-PET/CT: Alternative for cranial and extracranial assessment
- MRI (cranial): Alternative for temporal artery assessment
- CT angiography or MR angiography: For large vessel evaluation
Mandatory Large Vessel Assessment
All newly diagnosed GCA patients require baseline noninvasive vascular imaging 6:
- MR or CT angiography of neck/chest/abdomen/pelvis to detect large vessel involvement 6
- Establishes baseline for future monitoring of aneurysms, stenoses, and disease progression 6
- Critical for prognosis and determining need for routine vascular surveillance 6
If Initial Workup is Negative
With negative temporal artery biopsy, obtain noninvasive large vessel imaging with clinical reassessment 6 to evaluate for extracranial GCA, which may be missed by cranial-focused testing alone.
Critical Timing Considerations
- Do NOT delay glucocorticoid treatment while awaiting diagnostic confirmation 4
- Fast-Track Clinic model: appointment within 24 hours, examination by GCA expert, ≥50 suspected cases/year 5
- Biopsy remains valid up to 2 weeks after starting steroids (though sooner is better) 6
Common Pitfalls
- Relying on ESR alone: CRP is more sensitive (100% vs 92%); use both 1
- Short biopsy segments: <1 cm reduces diagnostic yield due to skip lesions 6
- Skipping large vessel imaging: Misses extracranial disease and prognostic information 6
- Bilateral biopsies routinely: Start unilateral unless symptoms clearly bilateral 6
- Delaying treatment for diagnostics: Start high-dose glucocorticoids immediately if clinical suspicion is high 4
Geographic/Resource Considerations
The ACR (US-focused) and EULAR (European) guidelines diverge on imaging vs. biopsy preference 3. In settings with experienced ultrasound operators, use ultrasound first 3, 4, 2. In settings without ultrasound expertise, proceed directly to temporal artery biopsy 6.